BTK inhibitor CGI1746, Purity ≥98%

Cat. No.: X24-06-ZQ435

BTK inhibitor CGI1746, Purity ≥98%

Synonym: 910232-84-7; BTK inhibitor; CGI 1746; CGI-1746

  • MDL: MFCD18782602
  • CAS Number: 910232-84-7
  • Compound CID: 24857323
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Price
Datasheet
MSDS
Properties
Description
CGI1746, soluble in DMSO and warmed ethanol and insoluble in water, is a compound designed to block Bruton’s tyrosine kinase (BTK), an enzyme essential for the proliferation and survival of certain cancerous B cells.
Molecular Weight
579.7
Molecular Formula
C34H37N5O4
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 91 mg/mL (156.98 mM); Water: Insoluble; Warmed ethanol: 30 mg/mL (51.75 mM)
Identity
Confirmed by NMR/HPLC/MS.
Applications
CGI1746 is explored for its efficacy in blocking BTK activity, contributing to potential treatments for conditions like chronic lymphocytic leukemia.
Related Products

Christmas 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0